Brief supporting Juul’s appeal against FDA denial of its products

July 2022: United States
Legal Filing

Amicus brief filed in the DC Appeals Court in Juul vs FDA case

On 23 June 2022, FDA denied Juul’s applications to market its products in the United States. Juul is challenging this vindictive, arbitrary and capricious decision in court. David Abrams, Scott Ballin, Martin Jarvis, David Sweanor and I filed an amici curiae brief in support of Juul’s motion for a stay pending substantive review on public health grounds.

Some relevant documentation here:

Documents are also available via the Court Docket for the case.

For background, see my blog: The FDA forces Juul to pull the most successful anti-smoking product ever

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Scroll to Top